Vijaypd Ceutical Limited

Vijaypd Ceutical Limited

NNSE:VIJAYPD
82.90
INR
+2.55
(+3.17%)
Vijaypd Ceutical Limited
NSE:VIJAYPD
(National Stock Exchange of India)

Recent

price

82.90

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Semi-annual Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Semi-annual Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Semi-annual Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
Vijaypd Ceutical Limited is an India-based pharmaceutical and healthcare company engaged in the development, manufacturing, marketing, and distribution of pharmaceutical formulations, active pharmaceutical ingredients, and wellness products. The company operates across multiple therapeutic segments, offering a comprehensive portfolio of finished dosage forms and specialized healthcare solutions. Its primary product and service offerings comprise solid oral dosage forms, including generic and branded tablets, sustained-release tablets, and hard and soft gelatin capsules; oral liquid preparations, including pediatric suspensions, cough syrups, and therapeutic solutions; sterile injectables, including liquid injectables, lyophilized vials, and large-volume parenterals; topical medications, consisting of dermatological ointments, antiseptic creams, gels, and lotions; dry syrup formulations and oral rehydration salts; active pharmaceutical ingredients (APIs) and specialty intermediates; and nutraceutical supplements, comprising dietary vitamins, mineral complexes, and immunity-enhancing formulations. In addition to manufacturing its proprietary formulation lines, Vijaypd Ceutical provides contract manufacturing and third-party formulation services, including formulation research and development, custom batch synthesis, analytical testing, quality assurance, regulatory dossier compilation, and specialized packaging solutions for institutional and commercial clients. The company serves a broad customer base that includes retail pharmacy chains, hospitals, healthcare institutions, government health departments, and wholesale distributors. Geographically, Vijaypd Ceutical maintains extensive domestic distribution networks across India while exporting select generic pharmaceuticals and healthcare supplies to emerging markets in Southeast Asia, Africa, and the Middle East. Headquartered in Mumbai, India, the company was founded in 1995. In recent corporate developments, Vijaypd Ceutical has executed several strategic initiatives to expand its commercial footprint and optimize its manufacturing infrastructure. Over the past two years, the company has completed major facility upgrades to expand production throughput and comply with updated Good Manufacturing Practice (GMP) and global regulatory standards. The company has also broadened its commercial portfolio with the launch of new formulation lines targeting high-demand cardiovascular, anti-diabetic, and respiratory therapeutic segments. Furthermore, Vijaypd Ceutical has entered into strategic co-distribution and supply partnerships with regional healthcare distributors to enhance market reach across tier-2 and tier-3 markets, while implementing digital supply chain integration systems to enhance procurement efficiency and product traceability.